Literature DB >> 2941281

Effect of oral ciprofloxacin on the faecal flora of healthy volunteers.

H A Holt, D A Lewis, L O White, S Y Bastable, D S Reeves.   

Abstract

The effect of oral ciprofloxacin on the intestinal flora was investigated in six male volunteers aged between 21 and 54 years. Faecal specimens were cultured quantitatively for aerobic and anaerobic micro-organisms before, during and after a five day course of ciprofloxacin. Ciprofloxacin resulted in a significant reduction in aerobic flora in all volunteers and colonisation with resistant coagulase-negative staphylococci or corynebacteria in two volunteers. The total anaerobic flora counts were significantly reduced in only one volunteer. Neither Clostridium difficile nor its toxin was detected and there was no significant colonisation with Pseudomonas spp. or yeasts; no ciprofloxacin-resistant gram-negative bacilli were detected. Peak serum levels on days 1 and 5 of 1.6-4.3 mg/l (mean 2.7) were achieved after 30-90 min and urine recovery over the five days was 27.1-44.6%.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2941281     DOI: 10.1007/bf02013987

Source DB:  PubMed          Journal:  Eur J Clin Microbiol        ISSN: 0722-2211            Impact factor:   3.267


  9 in total

1.  Effect of cefoperazone on faecal flora.

Authors:  K Alestig; H Carlberg; C E Nord; B Trollfors
Journal:  J Antimicrob Chemother       Date:  1983-08       Impact factor: 5.790

2.  Changes in the pharmacokinetics of ciprofloxacin and fecal flora during administration of a 7-day course to human volunteers.

Authors:  W Brumfitt; I Franklin; D Grady; J M Hamilton-Miller; A Iliffe
Journal:  Antimicrob Agents Chemother       Date:  1984-11       Impact factor: 5.191

3.  Multiple-dose pharmacokinetics of ceftazidime and its influence on fecal flora.

Authors:  B Kemmerich; H Warns; H Lode; K Borner; P Koeppe; H Knothe
Journal:  Antimicrob Agents Chemother       Date:  1983-09       Impact factor: 5.191

4.  Effect of broad-spectrum cephalosporins on the microbial flora of recipients.

Authors:  G P Bodey; V Fainstein; I Garcia; B Rosenbaum; Y Wong
Journal:  J Infect Dis       Date:  1983-11       Impact factor: 5.226

5.  Resistance among fecal flora of patients taking sulfamethoxazole-trimethoprim or trimethoprim alone.

Authors:  R L Guerrant; S J Wood; L Krongaard; R A Reid; R H Hodge
Journal:  Antimicrob Agents Chemother       Date:  1981-01       Impact factor: 5.191

6.  In-vitro studies with ciprofloxacin, a new 4-quinolone compound.

Authors:  D S Reeves; M J Bywater; H A Holt; L O White
Journal:  J Antimicrob Chemother       Date:  1984-04       Impact factor: 5.790

7.  Impact of single dose as compared to three dose prophylaxis with latamoxef (moxalactam) on the colonic microflora in patients undergoing colorectal surgery.

Authors:  L Kager; A S Malmborg; C E Nord; S Sjöstedt
Journal:  J Antimicrob Chemother       Date:  1984-08       Impact factor: 5.790

8.  Alterations in human fecal flora, including ingrowth of Clostridium difficile, related to cefoxitin therapy.

Authors:  M E Mulligan; D Citron; E Gabay; B D Kirby; W L George; S M Finegold
Journal:  Antimicrob Agents Chemother       Date:  1984-09       Impact factor: 5.191

9.  Effect of bacampicillin on human mouth, throat and colon flora.

Authors:  A Heimdahl; C E Nord; K Weilander
Journal:  Infection       Date:  1979       Impact factor: 3.553

  9 in total
  16 in total

Review 1.  Selective decontamination in neutropenic patients.

Authors:  E Kurrle; T Schmeiser; W Kern
Journal:  Epidemiol Infect       Date:  1992-12       Impact factor: 2.451

2.  Influence of intravenously administered ciprofloxacin on aerobic intestinal microflora and fecal drug levels when administered simultaneously with sucralfate.

Authors:  W A Krueger; G Ruckdeschel; K Unertl
Journal:  Antimicrob Agents Chemother       Date:  1997-08       Impact factor: 5.191

3.  Posttreatment changes in Escherichia coli antimicrobial susceptibility rates among diarrheic patients treated with ciprofloxacin.

Authors:  Shannon D Putnam; John W Sanders; David R Tribble; David R Rockabrand; Mark S Riddle; Patrick J Rozmajzl; Robert W Frenck
Journal:  Antimicrob Agents Chemother       Date:  2005-06       Impact factor: 5.191

Review 4.  Effect of quinolones on the human intestinal microflora.

Authors:  C E Nord
Journal:  Drugs       Date:  1995       Impact factor: 9.546

Review 5.  Effect of quinolones on intestinal ecology.

Authors:  C Edlund; C E Nord
Journal:  Drugs       Date:  1999       Impact factor: 9.546

6.  Decontaminating efficacy of ciprofloxacin in an animal model.

Authors:  M L van Ogtrop; H Mattie; H F Guiot; R van Furth
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1989-10       Impact factor: 3.267

Review 7.  Impact of the fluoroquinolones on gastrointestinal flora.

Authors:  V Korten; B E Murray
Journal:  Drugs       Date:  1993       Impact factor: 9.546

8.  Multiple-dose pharmacokinetics of sparfloxacin and its influence on fecal flora.

Authors:  M Ritz; H Lode; M Fassbender; K Borner; P Koeppe; C E Nord
Journal:  Antimicrob Agents Chemother       Date:  1994-03       Impact factor: 5.191

Review 9.  A review on the impact of 4-quinolones on the normal oropharyngeal and intestinal human microflora.

Authors:  C Edlund; C E Nord
Journal:  Infection       Date:  1988       Impact factor: 3.553

Review 10.  Use of quinolones in the treatment of gastrointestinal infections.

Authors:  H L DuPont
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1991-04       Impact factor: 3.267

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.